(Q35922093)

11 August 2017

Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted (English)

1 reference

11 August 2017

Olivier Lambert

1

1 reference

11 August 2017

Dirk Bandilla

2

1 reference

11 August 2017

Rupa Iyer

3

1 reference

11 August 2017

Leonore Witchey-Lakshmanan

4

1 reference

11 August 2017

Nagesh Palepu

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

28 March 2012

1 reference

Drug Design, Development and Therapy

11 August 2017

1 reference

11 August 2017

6

1 reference

11 August 2017

61-70

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

11 August 2017

start time

1 March 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Treatment of pulmonary arterial hypertension

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Interaction of arginine with proteins and the mechanism by which it inhibits aggregation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Guidelines for the diagnosis and treatment of pulmonary hypertension.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340107

Isolation of prostacyclin from whole blood

24 September 2018

1 reference

12 December 2020

Reduced hydrolytic lability of epoprostenol in the presence of cationic micelles

1 reference

12 December 2020

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

12 December 2020

In vitro hemolysis: guidance for the pharmaceutical scientist

1 reference

12 December 2020

Identifiers

DOI

10.2147/DDDT.S29916

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22563237

1 reference